Bayer had only just started to recover from the glyphosate debacle in the USA, the next bad news is already on the horizon. At the same time, the paper has now fallen back to a fresh 9-year low and could be passed on.
Has visibility within two days Bayer The news has lost around 17.50 percent of its value and has moved into the range of the previous year’s lows from mid-March. It already went down sharply in yesterday’s trade. A new annual low for the weekend. The trigger for this was a lowered outlook for this year. In the agricultural sector in particular, growth expectations were significantly reduced during the Corona crisis, it said. This situation is unlikely to change in the near future. The direct effects of the pandemic would be more profound here than initially expected. The receipt followed promptly.
Weekly closing rate crucial
Should the weakness be in the BayerIf the share continues and at least a weekly closing price below 44.85 euros is achieved, this could have medium-term effects on the price development of the security and mean further discounts on the broad horizontal support from the years 2009/2011 of 35.30 euros. However, this will only have to show in the next few weeks. Until then, the security is likely to be very volatile anyway; Bayer– The share is expected to reach 50.00 euros, but higher profits than the level of around 52.00 euros should not be achieved.
- Resistances: 44.86; 46.59; 49.88; 51.32; 53.05; 54.70 euros
- Supports: 43.87; 42.38; 41.84; 38.82; 37.38; 36.78 euros
Bayer in euros in the daily chart; 1 candle = 1 day (logical candle chart display)
Observation period: 29.10.2019 – 02.10.2020. Historical considerations are not reliable indicators for future developments. Source: tradingdesk.onemarkets.de/underlying/DE000BAY0017
Bayer in Euro in the weekly chart; 1 candle = 1 week (logical candle chart display)
Observation period: 28.09.2015 – 02.10.2020. Historical considerations are not reliable indicators for future developments. Source: tradingdesk.onemarkets.de/underlying/DE000BAY0017
Products on Bayer shares and other underlyings can be found at: www.onemarkets.de
NEW: Cashback trading – when the issuer pays my order fees!
Please note the important information and the disclaimer.
This information does not constitute investment advice, but advertising. The public offer is made exclusively on the basis of a securities prospectus approved by the Federal Financial Supervisory Authority (“BaFin”). Approval of the prospectus should not be understood as a recommendation to purchase these UniCredit Bank AG securities. Only the prospectus including any supplements is relevant and the Final Terms. It is recommended that you read these documents carefully before making any investment decision in order to fully understand the potential risks and rewards of investing. You are about to acquire a product that is not easy and can be difficult to understand.
How the HVB products work
The Bayer share contribution slips to a nine-year low first appeared on onemarkets blog (HypoVereinsbank – UniCredit Bank AG).
Note: PERSONAL-FINANCIAL.COM publishes analyzes, columns and news from various sources in this section. PERSONAL-FINANCIAL.COM AG is not responsible for content that has been recognized by third parties in the “News” section of this website and does not adopt it as its own. This content can be identified in particular by a corresponding “from” mark below the article heading and / or by the link “To read the full article, please click here.”; The named third party is solely responsible for this content.